Project Grant R01DK140369

Award Date 8/22/24
Completion Date 6/30/28
Dollars Obligated $852K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Wauwatosa, WI 53226, USA
Similar Awards
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $984,000 Project Grant to the University of Chicago to test a novel treatment for the prevention of recurrent calcium phosphate kidney stones. The research aims to evaluate the effectiveness of sodium glucose co-transporter-2 inhibitor medications in reducing the recurrence of this type of kidney stone, which has the...
This Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA Program 93.350 provides funding of $437,761 to the University of Texas at Austin for a 2-year research project from August 2024 to July 2026. The project aims to determine if a human enzyme therapeutic that degrades cystine can prevent or slow the formation of cystine kidney stones and mitigate associated kidney pathology in a mouse model of cystinuria, a rare metabolic disorder causing...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to leverage a unique dog model to investigate the role of the protein uromodulin in kidney stone disease. The $368,500 award, effective September 1, 2024 through August 31, 2025, will support research to identify how defects in uromodulin polymerization and peptide excretion impact renal...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $278,224 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Sonomotion Inc., a for-profit organization located in San Mateo, CA. The grant supports the development of Burst Wave Lithotripsy (BWL) technology to fragment large kidney stones in the 10-20 mm range. The proposed work will address technical challenges in creating a compact, high-pressure...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $2,967,657 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Mayo Clinic Jacksonville, a nonprofit organization. The grant supports a 4-year research project to investigate the role of urinary urate in regulating water homeostasis and suppressing cyst formation in autosomal dominant polycystic kidney disease (ADPKD). Key objectives include...
This $191,160 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research by Dr. David Bayne at the University of California, San Francisco (UCSF) to leverage electronic health record (EHR) data to identify patients at risk of being lost to follow-up after diagnosis of urinary stone disease in the emergency department. The funding will enable Dr. Bayne to: (1)...
This federal Project Grant award of $690,340 from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will support scientific research on phosphate and enamel formation at the University of Southern California (USC). The research aims to advance the understanding of active transcellular and intracellular phosphate movements and their role in enamel mineralization processes. The project will leverage five unique...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $166,740.00 to the University of Kansas Medical Center Research Institute, Inc. to conduct research aimed at defining the role of phosphaturia in the mechanisms of chronic kidney disease (CKD) progression. The key goals are to: (1) Define how chronic phosphaturia impacts CKD...
This Project Grant award of $809,427, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to understand the impact of polymicrobial interactions and within-host adaptation on the pathogenesis of catheter-associated urinary tract infections (CAUTI). The research aims to elucidate how the three most common urinary tract colonizers - Enterococcus...
This $151,069 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support research to investigate the determinants of protein uptake along the kidney proximal tubule, focusing on how sex and alterations in glomerular filtration rate and permeability impact this process. The primary awardee, the University of Pittsburgh, will develop a multiscale model of protein uptake...

PROTEIN INTERACTIONS THAT CONTROL CALCIUM OXALATE STONE FORMATION - KIDNEY STONES REMAIN AN ENIGMATIC DISEASE DESPITE DECADES OF WORK BY MANY INVESTIGATORS WITH NO REAL ADVANCEMENT IN CALCIUM OXALATE (CAOX) STONE TREATMENT FOR MORE THAN 20 YEARS, BEYOND THE FOCUS ON LOWERING URINARY SUPERSATURATION WITH RESPECT TO CAOX CRYSTALS. WHILE THE RECURRENCE RATE CAN BE REDUCED, THE DISEASE CANNOT BE CURED WITH CURRENT THERAPIES. WITH PREVALENCE OF APPROXIMATELY 10% IN MOST DEVELOPED COUNTRIES AND INCREASING IN RECENT YEARS, RESEARCH THAT COULD DEFINE THE MECHANISMS UNDERLYING STONE FORMATION IS INCREASINGLY RELEVANT. ORGANIC MATERIALS (MAINLY PROTEINS) APPEAR TO COAT ALL CRYSTAL SURFACES IN CAOX STONES, AND THE PRESENCE OF PROTEINS APPEARS TO BE CRITICAL TO STONE FORMATION. THESE PROTEIN CRYSTAL AGGREGATES FORM SPONTANEOUSLY (SELF- ASSEMBLE) TO FORM DENSE SOLID OBJECTS WITH SUBSTANTIAL MECHANICAL STRENGTH. NO SINGLE PROTEIN IS CRITICAL TO THIS PROCESS. WE HAVE FOCUSED FOR MANY YEARS ON MIXTURES OF STRONG POLYANIONS (PA) WITH STRONG POLYCATIONS (PC), WHICH SELF AGGREGATE AT LOW CONCENTRATIONS AND INDUCE CAOX CRYSTAL AGGREGATION WHEN MIXED IN ROUGHLY EQUAL PROPORTIONS. DIRECT MEASUREMENTS OF PROTEIN COMPOSITIONS IN STONE MATRIX HAVE DEMONSTRATED ENRICHMENT OF PA AND PC IN STONES, BUT ALSO DEMONSTRATED A MAJOR FRACTION OF MANY WEAKLY IONIC PROTEINS THAT EXHIBIT PREFERENTIAL ADSORPTION TO STONE MATRIX COMPARED TO URINE. UNFORTUNATELY, THE SHEER NUMBER OF PROTEINS COMPRISING STONE MATRIX OBSCURES THE NATURE OF THEIR ROLE IN STONE FORMATION, YET THESE BROADLY CONSTITUTED MIXTURES CLEARLY YIELD HARD, DENSE AGGREGATES WHEN MIXED WITH CAOX CRYSTALS. THE PROTEIN MIXTURES FOUND IN OTHER KIDNEY STONE TYPES ARE SIMILAR IN MOST PROTEINS, AND OTHER MINERALIZED TISSUES, LIKE HUMAN BONE AND MOLLUSK SHELLS, CONTAIN SIMILARLY BROAD PROTEIN MIXTURES WITH MANY COMMON FEATURES. FURTHERMORE, STUDIES OF PA/PC MIXTURES IN POLYMER SCIENCE SHOW THAT THESE SYSTEMS PHASE SEPARATE (AGGREGATE), BUT DON'T ACHIEVE THE DENSE SOLID CONCENTRATIONS OF POLYMERS OBSERVED IN STONES. WE HYPOTHESIZE THAT CAOX STONE FORMATION IS DEPENDENT ON A COMPLEX MIXTURE OF PROTEINS, INCLUDING STRONGLY ANIONIC, STRONGLY CATIONIC, AND WEAKLY CHARGED PROTEINS THAT INTERACT WITH CAOX CRYSTALS TO PRODUCE THE DENSE PROTEIN-CRYSTAL AGGREGATES (COMPOSITES) WITH HIGH MECHANICAL STRENGTH THAT ARE KIDNEY STONES. WE WILL USE THE ESTABLISHED PROTEIN COMPOSITIONS OF CAOX STONE MATRIX AS A STARTING POINT FOR MAKING CONTROLLED MIXTURES OF WELL CHARACTERIZED POLYMERS AND PROTEINS AND STUDYING THEIR INTERACTIONS WITH CAOX CRYSTALS TO UNDERSTAND THE SELF-ASSEMBLY OF STONE LIKE COMPOSITES, AS WELL AS THEIR MECHANICAL PROPERTIES. OUR STUDY TEAM IS IDEALLY SUITED TO THIS TASK, INCLUDING A CLINICIAN WITH POLYMER PHYSICAL CHEMISTRY TRAINING AND KIDNEY STONE EXPERIENCE AND AN EXPERT IN CHEMICAL ENGINEERING AND POLYELECTROLYTE PHASE BEHAVIOR. THE PROPOSED WORK INCLUDES 3 SPECIFIC AIMS. 1: TEST A RANGE OF PROTEIN/POLYMER COMPOSITIONS FOR THEIR ABILITY TO ALTER CAOX CRYSTALLIZATION PROCESSES (NUCLEATION, GROWTH, AND AGGREGATION). 2: MEASURE THE MECHANICAL STRENGTH OF CAOX CRYSTAL AGGREGATES SPONTANEOUSLY FORMED WITH THESE MIXTURES. 3: PREPARE MACROSCOPIC COMPOSITES (SIMULATED STONES) FOR MECHANICAL TESTING TO BRIDGE UNDERSTANDING TO CLINICAL DISEASE.

Posted 8/22/24